Acrolein induces inflammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis.

Area of Science:

• Cardiovascular Biology
• Endothelial Cell Function
• Atherosclerosis Pathogenesis

Background:

• Endothelial dysfunction is a key link between atherosclerosis risk factors and disease mechanisms.
• Tobacco smoking promotes atherosclerosis, but the precise mechanisms remain unclear.
• Controlling endothelial cell inflammation is vital for limiting atherosclerosis.

Purpose of the Study:

• To investigate the role of acrolein, a tobacco smoke toxin, in endothelial dysfunction.
• To elucidate the molecular pathways linking acrolein exposure to inflammatory responses in endothelial cells.

Main Methods:

• Assessed oxidative stress by measuring thioredoxin reductase inactivation.
• Investigated cyclooxygenase-2 (COX-2) expression.
• Examined the activation of protein kinase C (PKC), p38 mitogen-activated protein kinase (MAPK), and cAMP response element-binding protein (CREB) pathways.

Main Results:

• Acrolein exposure led to thioredoxin reductase inactivation, increasing oxidative stress.
• Acrolein stimulated COX-2 expression in endothelial cells.
• The activation of PKC, p38 MAPK, and CREB pathways was observed following acrolein exposure.

Conclusions:

• Acrolein, a component of tobacco smoke, induces oxidative stress and inflammation in endothelial cells.
• Acrolein may contribute to the progression of atherosclerosis through these mechanisms.
• Targeting acrolein-mediated pathways could be a strategy for preventing smoking-related atherosclerosis.